Genpact Limited Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Genpact Limited (G) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $27.65 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-07
- Genpact Limited share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $27.65, a 34.86% decline year-over-year.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $42.45, a 45.83% increase year-over-year.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $29.11, a 45.99% increase year-over-year.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $19.94.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $34.49, a 14.93% increase from fiscal 2024.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $30.01, a 48.79% increase from fiscal 2023.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $20.17, a 8.77% decline from fiscal 2022.
- Genpact Limited share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $22.11, a 9.29% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.65 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $27.65 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $34.49 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $36.32 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $42.45 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | $42.45 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | $30.01 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $29.11 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $29.11 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | $29.11 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $20.17 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $19.76 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $19.76 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $19.94 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $22.11 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $26.87 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $27.65 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $20.23 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $20.50 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $18.05 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $23.97 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | $20.30 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $20.03 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $19.44 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $14.27 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $15.33 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $15.27 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | $14.37 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | $19.60 10-Q · filed 2019-05-10 | |||
| 2018-12-31 | $16.46 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $16.46 10-Q · filed 2018-11-09 | |||
| 2018-06-30 | $16.95 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | $15.76 8-K · filed 2018-06-04 | |||
| 2017-12-31 | $14.50 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $14.40 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | $14.17 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | $14.36 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | $14.98 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $15.79 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | $15.93 10-Q · filed 2016-08-08 | |||
| 2016-03-31 | $16.96 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | $9.49 8-K · filed 2018-06-04 | |||
| 2015-09-30 | $8.65 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $8.51 10-Q · filed 2015-08-07 | |||
| 2015-03-31 | $8.86 10-Q · filed 2015-05-08 | |||
| 2014-12-31 | $7.00 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $5.61 10-Q · filed 2014-11-07 | |||
| 2014-06-30 | $4.54 10-Q · filed 2014-08-08 | |||
| 2014-03-31 | $3.81 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | $9.31 10-K · filed 2016-02-26 | |||
| 2013-09-30 | $8.76 10-Q · filed 2013-11-08 | |||
| 2013-06-30 | $8.08 10-Q · filed 2013-08-09 | |||
| 2013-03-31 | $7.83 10-Q · filed 2013-05-10 | |||
| 2012-12-31 | $9.83 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $12.82 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | $8.40 10-Q · filed 2012-08-09 | |||
| 2011-12-31 | $10.64 10-K · filed 2014-02-28 | |||
| 2010-12-31 | $7.12 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Booz Allen Hamilton Holding Corp (BAH) | United States | $8.878B | 9.38 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |